SCHEMBL5872308

SCHEMBL5872308

N=C(N)NCCC[C@H](N)C(=O)CC(N)=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DPP7 Q9UHL4 2/20 0.39
▸ OTC P00480 1/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ MEN1 O00255 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ DDAH1 O94760 1/20 0.36
▸ NPY4R P50391 7/20 0.36
▸ NPY1R P25929 5/20 0.36
▸ NPY2R P49146 4/20 0.36
▸ NPY5R Q15761 4/20 0.36
▸ GNAI3 P08754 1/20 0.34
▸ GNAO1 P09471 1/20 0.34
▸ GNAI1 P63096 1/20 0.34
▸ NOS3 P29474 1/20 0.33
▸ NOS1 P29475 1/20 0.33
▸ NOS2 P35228 1/20 0.33
▸ ALB P02768 1/20 0.33
▸ CHRM2 P08172 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30531668 0.88 OTC (0.41) DPP7OTCALOX15MEN1CYP1A2
SCHEMBL19465128 0.86 DPP7 (0.39) DPP7OTCALOX15MEN1CYP1A2
SCHEMBL2186467 0.86 DPP7 (0.39) DPP7OTCALOX15MEN1CYP1A2
SCHEMBL2186462 0.86 DPP7 (0.39) DPP7OTCALOX15MEN1CYP1A2
SCHEMBL5872015 0.85 DPP7 (0.41) DPP7OTCALOX15KMT2ADDAH1
SCHEMBL25302510 0.85 OTC (0.39) DPP7OTCALOX15MEN1CYP1A2
SCHEMBL21027152 0.84 DPP7 (0.45) DPP7OTCALOX15MEN1CYP1A2
SCHEMBL22799242 0.84 NPY4R (0.38) DPP7OTCALOX15MEN1CYP1A2
SCHEMBL22799243 0.84 NPY4R (0.38) DPP7OTCALOX15MEN1CYP1A2
SCHEMBL18819440 0.84 DPP7 (0.45) DPP7OTCALOX15MEN1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2934565-A2 GHRH AGONISTS FOR THE TREATMENT OF ISCHEMIC DISORDERS University of Miami (US) 2015-10-28 — — EP disclosed
WO-2014100809-A2 GHRH AGONISTS FOR THE TREATMENT OF ISCHEMIC DISORDERS UNIVERSITY OF MIAMI (US) 2014-06-26 — — WO disclosed
US-7037897-B2 TRI-, TETRA-, and penta-peptides having antiangiogenic activity ABBOTT LABORATORIES (US) 2006-05-02 — — US disclosed
US-7001984-B2 Di-, tri-, and tetra-peptides having antiangiogenic activity ABBOTT LABORATORIES (US) 2006-02-21 — — US disclosed
US-20050215484-A1 Di-, tri-, and tetra-peptides having antiangiogenic activity HAVIV FORTUNA 2005-09-29 — — US disclosed
Send feedback